Pain Assessment in Children With Cerebral Palsy Through Parasympathetic Tone Analysis.
CompletedNCT02364856
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study evaluates Analgesia Nociception Index (Heart Rate Variability based index) and its variations after painful stimulations in children with cerebral palsy : acute procedural pain (botulinum toxin injections), and recurrent pain (physiotherapy).
Study details
- Official title
- Assessment of Pain Through Parasympathetic Tone Analysis : Applicability in Children With Cerebral Palsy.
- Conditions
- Cerebral Palsy
- Pain
- Children
- Interventions
- Device: Analgesia Nociception Index
- Sponsor
- University Hospital, Lille
- Collaborators
- Clinical Investigation Centre for Innovative Technology Network; Fondation Motrice
- Start date
- 2015-04-24
- Primary completion
- 2018-04-12
- Sex
- All
- Age range
- from 6 Years to 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- France
- Total sites listed
- 3
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Cerebral Palsy * Rehabilitation care with physiotherapy and/or toxinum botulinum injections * Absence of identified autonomic nervous system disease * Parental and children (if applicable) consent obtained * French National Health System cover Exclusion Criteria: * baseline Respiratory Frequency \> 30/min * beta-blockers or atropinic treatment * Pacemaker, cardiac rhythm disease * Diabetes mellitus
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02364856